Publications: Dr Mohammed Khan
Khan MA, Szabados B, Choy J, Jackson-Spence F, Powles T, Castellano D, Valderrama BP
(
2021
)
.
Patient outcomes following disease progression with enfortumab-vedotin (EV) in metastatic urothelial carcinoma (mUC)
.
Journal of Clinical Oncology
vol.
39
,
(
15_suppl
)
e16516
-
e16516
.